sucrose has been researched along with Hyperparathyroidism, Secondary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfieri, C; Cozzolino, M; Gallieni, M; Malberti, F; Mazzaferro, S; Messa, P; Russo, D | 1 |
| Botha, J; Chong, EM; Covic, AC; Floege, J; Ketteler, M; Rastogi, A; Sprague, SM | 1 |
1 review(s) available for sucrose and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
[Hyperphosphatemia in dialysis: which binder?]
Topics: Chelating Agents; Chelation Therapy; Cohort Studies; Drug Combinations; Ferric Compounds; Gastrointestinal Diseases; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Multicenter Studies as Topic; Patient Compliance; Phosphates; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Sucrose | 2018 |
1 trial(s) available for sucrose and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Biomarkers, Pharmacological; Bone Density Conservation Agents; Chelating Agents; Drug Combinations; Drug Interactions; Ergocalciferols; Female; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Middle Aged; Parathyroid Hormone; Receptors, Calcitriol; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Sucrose | 2016 |